相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association between circulating FGF23, α-Klotho, and left ventricular diastolic dysfunction among patients with preserved ejection fraction
Yusuke Okamoto et al.
HEART AND VESSELS (2016)
FGF21 attenuates pathological myocardial remodeling following myocardial infarction through the adiponectin-dependent mechanism
Yusuke Joki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Serum fibroblast growth factor 21 levels are increased in atrial fibrillation patients
Xinyuan Han et al.
CYTOKINE (2015)
FGF21 deletion exacerbates diabetic cardiomyopathy by aggravating cardiac lipid accumulation
Xiaoqing Yan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
Effects of fibroblast growth factor 21 on the heart
Pongpan Tanajak et al.
JOURNAL OF ENDOCRINOLOGY (2015)
Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21
Bryn M. Owen et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
FGF21 and cardiac physiopathology
Anna Planavila et al.
FRONTIERS IN ENDOCRINOLOGY (2015)
Fibroblast growth factor 21 protects the heart from oxidative stress
Anna Planavila et al.
CARDIOVASCULAR RESEARCH (2015)
Circulating levels of fibroblast growth factor-21 increase with age independently of body composition indices among healthy individuals
Lynae J. Hanks et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY (2015)
Heart Failure With Preserved Ejection Fraction Mechanisms, Clinical Features, and Therapies
Kavita Sharma et al.
CIRCULATION RESEARCH (2014)
Fibroblast growth factor 21, the endocrine FGF pathway and novel treatments for metabolic syndrome
Jun Zhang et al.
DRUG DISCOVERY TODAY (2014)
Fibroblast growth factor 21 is induced upon cardiac stress and alters cardiac lipid homeostasis
Manoja K. Brahma et al.
JOURNAL OF LIPID RESEARCH (2014)
Noncardiac Comorbidities in Heart Failure With Reduced Versus Preserved Ejection Fraction
Robert J. Mentz et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Implications of Coronary Artery Disease in Heart Failure With Preserved Ejection Fraction
Seok-Jae Hwang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease
Yun Shen et al.
CARDIOVASCULAR DIABETOLOGY (2013)
Temporal Relationship and Prognostic Significance of Atrial Fibrillation in Heart Failure Patients With Preserved Ejection Fraction: A Community-Based Study
Rosita Zakeri et al.
CIRCULATION (2013)
Elevated serum fibroblast growth factor 21 is associated with hypertension in community-dwelling adults
R. D. Semba et al.
JOURNAL OF HUMAN HYPERTENSION (2013)
Fibroblast growth factor 21 protects against cardiac hypertrophy in mice
A. Planavila et al.
NATURE COMMUNICATIONS (2013)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
John J. V. McMurray et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2012)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
John J. V. McMurray et al.
EUROPEAN HEART JOURNAL (2012)
Fibroblast Growth Factor 21 Action in the Brain Increases Energy Expenditure and Insulin Sensitivity in Obese Rats
David A. Sarruf et al.
DIABETES (2010)
Research Resource: Comprehensive Expression Atlas of the Fibroblast Growth Factor System in Adult Mouse
Klementina Fon Tacer et al.
MOLECULAR ENDOCRINOLOGY (2010)
Revised Equations for Estimated GFR From Serum Creatinine in Japan
Seiichi Matsuo et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
Sherif F. Nagueh et al.
EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY (2009)
FGF-21/FGF-21 receptor interaction and activation is determined by βKlotho
Alexei Kharitonenkov et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
How to diagnose diastolic heart failure:: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology
Walter J. Paulus et al.
EUROPEAN HEART JOURNAL (2007)
Hepatic fibroblast growth factor 21 is regulated by PPARα and is a key mediator of hepatic lipid metabolism in ketotic states
Michael K. Badman et al.
CELL METABOLISM (2007)
Outcome of heart failure with preserved ejection fraction in a population-based study
R. Sacha Bhatia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Trends in prevalence and outcome of heart failure with preserved ejection fraction
Theophilus E. Owan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy
J Asbun et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Recommendations for chamber quantification: A report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology
RM Lang et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2005)
FGF-21 as a novel metabolic regulator
A Kharitonenkov et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Diastolic heart failure: Neglected or misdiagnosed?
P Banerjee et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population - The LIFE study
K Wachtell et al.
HYPERTENSION (2000)
分享论文
